Tissue Based Genomic Profiling Market to Grow with a CAGR of 6.65% Globally through 2029
Rising technological advancements in autonomous surgical
robotics is expected to drive the Global Tissue Based Genomic Profiling Market
in the forecast period 2025-2029.
According to TechSci Research report, “Tissue Based
Genomic Profiling Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2019-2029F”, the Global
Tissue Based Genomic Profiling Market stood at USD 1.37 billion in 2023 and is
anticipated to grow with a CAGR of 6.65% thriugh 2029.
Tissue-based genomic profiling is a sophisticated methodology crucial for uncovering the genetic composition of tissues, aiding informed medical decision-making. This state-of-the-art approach involves a thorough analysis of genomic alterations within a patient's tissue sample, providing vital insights into genetic mutations, changes, and biomarkers associated with various diseases, with a particular emphasis on cancer. By delving deep into the molecular intricacies of the genomic landscape, tissue-based genomic profiling serves as a cornerstone in implementing personalized medicine strategies.
Tissue-based genomic profiling represents a paradigm shift in healthcare, enabling clinicians to leverage genomic insights for personalized patient care and precision medicine. As this field continues to advance, it promises to revolutionize disease diagnosis, treatment selection, and patient outcomes across various medical specialties.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global
Tissue Based Genomic Profiling Market”
The Global Tissue Based Genomic Profiling Market is
segmented into technology, application, end-user, regional distribution, and company.
Based on Application, the market is
divided into Personalized Medicine, Oncological
Diagnostics, Research. Oncological Diagnostics dominated the market in
2023.The dominance of oncological diagnostics in the market stems primarily from their pivotal role in early cancer detection and the formulation of personalized treatment strategies. The imperative to detect cancer at its earliest stages to enable optimal intervention drives the demand for oncological diagnostics. Advanced technologies, particularly in genomics and molecular profiling, facilitate precise identification of genetic alterations, thereby enabling the implementation of targeted therapies tailored to individual patients.
As the global incidence of cancer continues to rise, there is an increasing emphasis on the need for accurate and comprehensive oncological diagnostics. This reinforces its position as a frontline approach in the healthcare market for effectively combating and managing cancer. As healthcare systems and providers worldwide endeavor to improve patient outcomes and alleviate the burden of cancer, the importance of oncological diagnostics remains paramount. It serves not only as a means of early detection but also as a cornerstone in the development of personalized treatment regimens, ultimately contributing to enhanced patient care and outcomes.
Major companies operating in Global Tissue Based
Genomic Profiling Market are:
- Foundation Medicine
Inc
- Illumina, Inc.
- QIAGEN N.V.
- Roche Diagnostics
Corp
- Thermo Fisher
Scientific Inc.
- Exact Sciences Corp
- Personal Genome
Diagnostics Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The Global Tissue-Based Genomic Profiling Market is driven by several factors, including the increasing prevalence of complex diseases, particularly cancer, which propels demand for personalized treatment strategies. Technological advancements in genomics, such as Next-Generation Sequencing (NGS) and Artificial Intelligence (AI), enhance the accuracy and efficiency of genomic analysis. Collaborations between biotech firms and academic institutions foster innovation, while the expansion of biobanks contributes to diverse and well-curated tissue samples. The trend towards adopting liquid biopsy techniques and integrating multiple omics data broadens the application areas, driving market growth by providing comprehensive insights into genomic alterations for improved diagnostics and targeted therapies”, said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Tissue Based Genomic Profiling Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Sequencing Techniques, Immunohistochemistry, Others), By Application (Personalized Medicine, Oncological Diagnostics, Research), By End-User (Research Institutes, Clinical Research Organizations, Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global
Tissue Based Genomic Profiling Market and provides statistics & information
on market size, structure and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in Global
Tissue Based Genomic Profiling Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com